Company
VALAR LABS
Analyzing the tumor to predict cancer treatment response
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- physicians and leading pharmaceutical companies
- valarlabs.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
Our diagnostics use AI to interpret solid tumors, so physicians and patients can make evidence-based decisions about cancer treatments
Funding snapshot
- Total raised
- $22MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $22M2024-05-30
Funding rounds
- Series A
- $22M2024-05-30, Company stated
Products
- Web
- Vesta
Loading relationship preview